Immunotherapy for advanced or metastatic urothelial carcinoma

Philipp Maisch, Eu Chang Hwang, Vikram Narayan, Caitlin J. Bakker, Frank Kunath, Philipp Dahm

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma.

Original languageEnglish (US)
Article numberCD013774
JournalCochrane Database of Systematic Reviews
Volume2020
Issue number11
DOIs
StatePublished - 2020

Bibliographical note

Funding Information:
We thank?the Cochrane Urology Editorial Group, the Methodological?Group and the Cancer Network for their support of this review. We thank G?nter Niegisch, Gunhild von Amsberg, Georgios?Gakis and Andrea Kokorovic?for reviewing the protocol.

Publisher Copyright:
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

Fingerprint Dive into the research topics of 'Immunotherapy for advanced or metastatic urothelial carcinoma'. Together they form a unique fingerprint.

Cite this